- To establish standard risk rating criteria of aGVHD biomarkers;
- To verify the role of aGVHD biomarkers monitored in predicting aGVHD risks;
- To determine the correlation between aGVHD biomarkers monitored and aGVHD risk;
- To carry out a observative study in patients with aGVHD treatment about therapeutic protocols and medication efficacy;
- To predict the correlation between the high-risk patients with aGVHD and non-relapse mortality and disease free survival;

